Complement and glomerular diseases

Area of Science:

• Immunology
• Nephrology
• Pathogenesis of Glomerular Diseases

Background:

• The complement pathway is integral to the immune system, influencing innate and adaptive responses.
• Clinical evidence, including biopsy findings and genetic data, links complement to glomerular disease pathogenesis.
• Animal models provide mechanistic insights into complement's role in kidney pathology.

Purpose of the Study:

• To review the role of the complement system in the pathogenesis of glomerular diseases.
• To discuss evidence from human patients and animal models for specific glomerular diseases.
• To explore potential therapeutic implications targeting the complement pathway.

Main Methods:

• Review of clinical findings in patients with glomerular diseases.
• Analysis of data from animal models of glomerular diseases.
• Synthesis of information on complement components, autoantibodies, and genetic mutations.

Main Results:

• Complement activation is implicated in atypical hemolytic uremic syndrome, C3 glomerulopathy, ANCA vasculitis, lupus nephritis, and membranous nephropathy.
• Presence of complement in biopsies and genetic factors correlate with disease development.
• Consumption of complement factors in circulation indicates active disease.

Conclusions:

• The complement pathway plays a significant role in the development and progression of various glomerular diseases.
• Targeting the complement system presents a promising therapeutic strategy for managing these kidney conditions.
• Further research into complement-mediated mechanisms can refine treatment approaches for glomerular pathologies.